PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.53%
Revenue growth of 2.53% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
4.70%
Gross profit growth of 4.70% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
33.61%
EBIT growth of 33.61% while Healthcare median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
19.88%
Operating income growth of 19.88% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand.
11.98%
Net income growth of 11.98% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
11.99%
EPS growth of 11.99% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
11.99%
Diluted EPS growth of 11.99% while Healthcare median is zero. Walter Schloss might see a slight edge that could improve over time.
-0.00%
Share reduction while Healthcare median is 0.32%. Seth Klarman would see a relative advantage if others are diluting.
-0.00%
Diluted share reduction while Healthcare median is 0.34%. Seth Klarman would see an advantage if others are still diluting.
-100.00%
Dividend cuts while Healthcare median is 0.00%. Seth Klarman would see if others maintain or grow payouts, highlighting a relative weakness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.19%
10Y CAGR of 38.19% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
49.64%
5Y CAGR of 49.64% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
23.37%
3Y CAGR of 23.37% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
39.11%
Net income/share CAGR exceeding 1.5x Healthcare median of 15.18% over a decade. Joel Greenblatt might see a standout compounder of earnings.
35.31%
5Y net income/share CAGR > 1.5x Healthcare median of 19.29%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
27.80%
3Y net income/share CAGR > 1.5x Healthcare median of 9.02%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
180.29%
Equity/share CAGR exceeding 1.5x Healthcare median of 20.78% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
118.59%
5Y equity/share CAGR > 1.5x Healthcare median of 19.83%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
55.15%
3Y equity/share CAGR > 1.5x Healthcare median of 12.14%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-19.00%
AR shrinking while Healthcare median grows. Seth Klarman sees potential advantage unless it signals declining demand.
-0.48%
Decreasing inventory while Healthcare is rising. Seth Klarman might see an efficiency advantage or possibly a sign of weaker sales future.
0.68%
Asset growth of 0.68% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
2.68%
BV/share growth of 2.68% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
-50.19%
Debt is shrinking while Healthcare median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
0.98%
SG&A growth far above Healthcare median. Jim Chanos sees potential red flags in cost management or diminishing returns on spending.